Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update  GlobeNewswireOpus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates  Yahoo FinanceOpus Genetics earnings beat by $0.07, revenue fell short of estimates  Investing.comOpus Genetics: Navigating Financial Challenges with Promising Clinical Catalysts  AInvestOpus Genetics hits major milestones as eye disease treatments show promising results in multiple trials  Stock Titan